Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 2026 entries
View as:

18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT06880328 Org: User:
Start: 11/07/18 End: 09/04/19 Due: 09/04/20

A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01119859 Org: User:
Start: 05/31/10 End: 01/31/12 Due: 01/31/13

A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01921478 Org: User:
Start: 08/31/10 End: 11/30/10 Due: 11/30/11

A Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics (PK) of RO7079901

Phase: N/A Priority: Normal
NCT ID: NCT02975388 Org: User:
Start: 12/20/16 End: 07/06/17 Due: 07/06/18

A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies

Phase: N/A Priority: Normal
NCT ID: NCT02097745 Org: User:
Start: 06/30/04 End: 06/30/13 Due: 06/30/14

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT05763576 Org: User:
Start: 04/28/23 End: 12/23/24 Due: 12/23/25

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01632228 Org: User:
Start: 06/29/12 End: 01/21/16 Due: 01/21/17

An Observational Study of Herceptin SC Safety in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02305628 Org: User:
Start: 06/26/15 End: 01/31/20 Due: 01/31/21

A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations

Phase: N/A Priority: Normal
NCT ID: NCT01342965 Org: User:
Start: 03/31/11 End: 04/30/14 Due: 04/30/15

A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)

Phase: N/A Priority: Normal
NCT ID: NCT01920633 Org: User:
Start: 10/31/13 End: 01/31/15 Due: 01/31/16

An Observational Study Examining the Use of Triple Combination Therapy With Boceprevir, Peginterferon Alfa-2a and Ribavirin in the Re-Treatment of Chronic Hepatitis C Patients

Phase: N/A Priority: Normal
NCT ID: NCT02118597 Org: User:
Start: 05/31/14 End: 05/31/15 Due: 05/31/16

A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.

Phase: N/A Priority: Normal
NCT ID: NCT00545532 Org: User:
Start: 02/04/08 End: 05/02/17 Due: 05/02/18

A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531

Phase: N/A Priority: Normal
NCT ID: NCT02956850 Org: User:
Start: 12/12/16 End: 06/15/21 Due: 06/15/22

A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00002239 Org: User:
Start: 05/31/99 End: - Due: -

A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02586051 Org: User:
Start: 11/19/15 End: 11/26/18 Due: 11/26/19

A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00806923 Org: User:
Start: 02/28/05 End: 02/28/11 Due: 02/28/12

A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00106574 Org: User:
Start: 04/30/05 End: 12/31/07 Due: 12/31/08

An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01809314 Org: User:
Start: 03/31/08 End: 10/31/09 Due: 10/31/10

A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

Phase: N/A Priority: Normal
NCT ID: NCT01181024 Org: User:
Start: 04/30/10 End: 10/31/10 Due: 10/31/11

A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01655381 Org: User:
Start: 04/30/12 End: 07/31/15 Due: 07/31/16

A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01665430 Org: User:
Start: 07/31/12 End: 02/28/15 Due: 02/28/16

A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01649804 Org: User:
Start: 07/31/12 End: 12/31/14 Due: 12/31/15

A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01620931 Org: User:
Start: 11/30/11 End: 11/30/12 Due: 11/30/13

A Non-Interventional Safety Study of Balsamic Bactrim

Phase: N/A Priority: Normal
NCT ID: NCT02902640 Org: User:
Start: 11/15/16 End: 07/31/17 Due: 07/31/18

Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02663232 Org: User:
Start: 06/30/13 End: 10/31/14 Due: 10/31/15